Related Experiment Video
Updated: Apr 7, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
Disease status in chronic inflammatory demyelinating polyneuropathy: inter-centre comparative analysis and correlates
Y A Rajabally1, J Cassereau2, A Robbe2
1Neuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester, UK.
Disease status in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) cohorts showed similar evolution profiles across two countries. Upper limb motor axonal loss is a potential electrophysiological marker for CIDP management.
Area of Science:
- Neurology
- Clinical Electrophysiology
- Immunology
Background:
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) exhibits variable clinical courses.
- Comparative analyses of CIDP evolution profiles between different patient cohorts are lacking.
- The correlation between CIDP disease status and objective measures of motor strength, function, and electrophysiology remains unclear.
Purpose of the Study:
- To compare the disease status evolution profiles of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) between two distinct patient cohorts.
- To investigate the relationship between CIDP disease status and clinical (motor strength, function) and electrophysiological parameters.
Main Methods:
- A simplified scale was utilized to assess disease status in two CIDP patient cohorts (Leicester, U.K., and Angers, France), totaling 72 subjects.
- Clinical and electrophysiological data from both cohorts were retrospectively analyzed.
- Disease status was independently ascertained in each cohort.
Main Results:
- Similar rates of remission, stable/improving disease, and unstable/active disease were observed in both cohorts.
- No significant correlation was found between disease status and motor strength or functional assessments.
- Median nerve compound muscle action potential amplitude emerged as the sole independent electrophysiological predictor of CIDP disease status (P = 0.046).
Conclusions:
- Disease status distribution in CIDP cohorts can serve as a valuable comparative indicator for management strategies.
- This distribution may aid in benchmarking healthcare service and treatment provision for CIDP.
- The degree of upper limb motor axonal loss, as assessed electrophysiologically, could be a useful marker for evaluating CIDP disease status.
More Related Videos
12:23Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Neural Regulation
Peripheral Artery Disease IV: Nursing Management